Research programme: recombinant alpha-1 antitrypsin therapeutics - AATec Medical
Latest Information Update: 06 Jan 2023
At a glance
- Originator AATec Medical
- Class Acute-phase proteins; Alpha globulins; Anti-inflammatories; Antiallergics; Antihyperglycaemics; Blood proteins; Secretory proteinase inhibitory proteins; Serpins
- Mechanism of Action Alpha 1-antitrypsin replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Autoimmune disorders; Respiratory tract infections
Most Recent Events
- 30 Nov 2022 Early research in Autoimmune disorders in Germany (Inhalation) (AATec Medical website, November 2022)
- 30 Nov 2022 Early research in Respiratory tract infections in Germany (Inhalation) (AATec Medical website, November 2022)